Ilona Argirion1, Katie R Zarins1, Julie J Ruterbusch2, Patravoot Vatanasapt3,4, Hutcha Sriplung5, Erlene K Seymour2, Laura S Rozek1. 1. Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, Michigan. 2. Wayne State University School of Medicine and Karmanos Cancer Institute, Detroit, Michigan. 3. Department of Otorhinolaryngology, Faculty of Medicine, Khon Kaen University, Thailand. 4. Khon Kaen Head and Neck Oncology Research, Khon Kaen University, Thailand. 5. Songkhla Cancer Registry, Prince of Songkla University, Songkhla, Thailand.
Abstract
BACKGROUND: The incidence of nasopharyngeal carcinoma (NPC) has been historically low in the United States. Although etiological factors differ by histological subtype, Epstein-Barr virus is accepted as the primary risk factor for nonkeratinizing NPC. In light of the changing epidemiology of viral-associated cancers, it is important to evaluate the temporal incidence of NPC in the United States. METHODS: Incidence and survival data from 1973 through 2015 were obtained from the Surveillance, Epidemiology, and End Results program. Stratified analyses were conducted to assess temporal trends in NPC by histological subtype, sex, and race. The data were analyzed using SAS and Joinpoint Regression Software to determine age-adjusted incidence rates, determine trends in the annual percent change, and calculate 5-year relative survival estimates and Kaplan-Meier curves. RESULTS: Although overall NPC incidence is decreasing in the United States, the nonkeratinizing differentiated subtype is starkly increasing, with an annual percent change of approximately 4% among white males (95% CI, 2.5%-5.2%), white females (95% CI, 1.9%-6.2%), and black males (95% CI, 2.0%, 5.7%); 2.7% among black females (95% CI, 0.8%, 4.6%); and 1.8% among women in the "other" race category (95% CI, 0.4%-3.3%). Racial disparities were noted, with 32% of nonkeratinizing NPC cases among blacks occurring before the age of 40 years. In addition, black males displayed consistently worse survival across all histological subtypes, whereas individuals in the "other" race category, particularly females, experienced the highest 5-year relative survival estimates. CONCLUSIONS: The current results indicate that the Epstein-Barr virus-related, differentiated NPC subtype is increasing across all sexes and races in the United States, with distinct incidence and survival disparities among blacks.
BACKGROUND: The incidence of nasopharyngeal carcinoma (NPC) has been historically low in the United States. Although etiological factors differ by histological subtype, Epstein-Barr virus is accepted as the primary risk factor for nonkeratinizing NPC. In light of the changing epidemiology of viral-associated cancers, it is important to evaluate the temporal incidence of NPC in the United States. METHODS: Incidence and survival data from 1973 through 2015 were obtained from the Surveillance, Epidemiology, and End Results program. Stratified analyses were conducted to assess temporal trends in NPC by histological subtype, sex, and race. The data were analyzed using SAS and Joinpoint Regression Software to determine age-adjusted incidence rates, determine trends in the annual percent change, and calculate 5-year relative survival estimates and Kaplan-Meier curves. RESULTS: Although overall NPC incidence is decreasing in the United States, the nonkeratinizing differentiated subtype is starkly increasing, with an annual percent change of approximately 4% among white males (95% CI, 2.5%-5.2%), white females (95% CI, 1.9%-6.2%), and black males (95% CI, 2.0%, 5.7%); 2.7% among black females (95% CI, 0.8%, 4.6%); and 1.8% among women in the "other" race category (95% CI, 0.4%-3.3%). Racial disparities were noted, with 32% of nonkeratinizing NPC cases among blacks occurring before the age of 40 years. In addition, black males displayed consistently worse survival across all histological subtypes, whereas individuals in the "other" race category, particularly females, experienced the highest 5-year relative survival estimates. CONCLUSIONS: The current results indicate that the Epstein-Barr virus-related, differentiated NPC subtype is increasing across all sexes and races in the United States, with distinct incidence and survival disparities among blacks.
Authors: K Sandvej; J W Gratama; M Munch; X G Zhou; R L Bolhuis; B S Andresen; N Gregersen; S Hamilton-Dutoit Journal: Blood Date: 1997-07-01 Impact factor: 22.113
Authors: Brigette B Y Ma; Terence C W Poon; K F To; Benny Zee; Frankie K F Mo; Charles M L Chan; Stephen Ho; Peter M L Teo; Phillip J Johnson; Anthony T C Chan Journal: Head Neck Date: 2003-10 Impact factor: 3.147
Authors: Chwee Ming Lim; Anthony Liou; Michelle Poon; Liang Piu Koh; Lip Kun Tan; Kwok Seng Loh; Bengt Fredrik Petersson; Eric Ting; Dario Campana; Boon Cher Goh; Noriko Shimasaki Journal: Cancer Immunol Immunother Date: 2022-01-30 Impact factor: 6.630
Authors: Katelyn O Stepan; Angela L Mazul; S Andrew Skillington; Randal C Paniello; Jason T Rich; Jose P Zevallos; Ryan S Jackson; Patrik Pipkorn; Sean Massa; Sidharth V Puram Journal: Head Neck Date: 2021-02-23 Impact factor: 3.821
Authors: Xingzhe Li; Sarin Kitpanit; Anna Lee; Dennis Mah; Kevin Sine; Eric J Sherman; Lara A Dunn; Loren S Michel; James Fetten; Kaveh Zakeri; Yao Yu; Linda Chen; Jung Julie Kang; Daphna Y Gelblum; Sean M McBride; Chiaojung J Tsai; Nadeem Riaz; Nancy Y Lee Journal: JAMA Netw Open Date: 2021-06-01